- Home
- Publications
- Publication Search
- Publication Details
Title
Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
Authors
Keywords
Multiple Sclerosis, Experimental Autoimmune Encephalomyelitis, Leflunomide, Fingolimod, Teriflunomide
Journal
DRUGS
Volume 74, Issue 6, Pages 659-674
Publisher
Springer Nature
Online
2014-04-16
DOI
10.1007/s40265-014-0212-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Christian Confavreux et al. LANCET NEUROLOGY
- Teriflunomide: A Review of Its Use in Relapsing Multiple Sclerosis
- (2013) Karly P. Garnock-Jones CNS DRUGS
- Drugs in Development for Relapsing Multiple Sclerosis
- (2013) Rehiana Ali et al. DRUGS
- The benefits and risks of alemtuzumab in multiple sclerosis
- (2013) Daniel Ontaneda et al. Expert Review of Clinical Immunology
- The astrocyte in multiple sclerosis revisited
- (2013) Celia F. Brosnan et al. GLIA
- The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro
- (2013) Li Li et al. JOURNAL OF NEUROIMMUNOLOGY
- Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients
- (2013) L. Michel et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Magnetic resonance imaging outcomes from a phase III trial of teriflunomide
- (2013) Jerry S Wolinsky et al. Multiple Sclerosis Journal
- Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?
- (2013) AH Nuyts et al. Multiple Sclerosis Journal
- ECTRIMS 2013: Posters I
- (2013) Multiple Sclerosis Journal
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
- (2013) Ashley H Beecham et al. NATURE GENETICS
- Reprogramming the immune repertoire with alemtuzumab in MS
- (2013) Heinz Wiendl et al. Nature Reviews Neurology
- Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis
- (2013) A. Bar-Or et al. NEUROLOGY
- Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
- (2013) Jeppe Romme Christensen et al. PLoS One
- Neurons as targets for T cells in the nervous system
- (2013) Roland S. Liblau et al. TRENDS IN NEUROSCIENCES
- IL-10-producing regulatory B cells (B10 cells) in autoimmune disease
- (2013) Ioannis Kalampokis et al. ARTHRITIS RESEARCH & THERAPY
- The Role of Natural Killer Cells in Multiple Sclerosis and Their Therapeutic Implications
- (2013) Coralie Chanvillard et al. Frontiers in Immunology
- Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation
- (2012) Peter J. Darlington et al. ANNALS OF NEUROLOGY
- Fingolimod Impedes Schwann Cell–Mediated Myelination
- (2012) Angelika Köhne et al. ARCHIVES OF NEUROLOGY
- Pregnancy outcome in women exposed to leflunomide before or during pregnancy
- (2012) M. Cassina et al. ARTHRITIS AND RHEUMATISM
- Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis
- (2012) Samuel A. Burns et al. BRAIN RESEARCH
- Regional Neural Activation Defines a Gateway for Autoreactive T Cells to Cross the Blood-Brain Barrier
- (2012) Yasunobu Arima et al. CELL
- Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling
- (2012) Haiyan Peng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- B cell exchange across the blood-brain barrier in multiple sclerosis
- (2012) H.-Christian von Büdingen et al. JOURNAL OF CLINICAL INVESTIGATION
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Altered frequency of T regulatory cells is associated with disability status in relapsing–remitting multiple sclerosis patients
- (2012) Lasse Bjerg et al. JOURNAL OF NEUROIMMUNOLOGY
- Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis
- (2012) Yan Gan et al. JOURNAL OF NEUROIMMUNOLOGY
- Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis
- (2012) Elias Toubi et al. JOURNAL OF NEUROIMMUNOLOGY
- Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis
- (2012) Rina Aharoni et al. JOURNAL OF NEUROIMMUNOLOGY
- Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years
- (2012) Christian Confavreux et al. Multiple Sclerosis Journal
- B cells and antibodies in multiple sclerosis pathogenesis and therapy
- (2012) Markus Krumbholz et al. Nature Reviews Neurology
- Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
- (2012) Ulf Schulze-Topphoff et al. PLoS One
- Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis
- (2012) Clara de Andrés et al. PLoS One
- Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis
- (2012) Thomas F. Benkert et al. PLoS One
- Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis
- (2012) Lars Börnsen et al. PLoS One
- Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK
- (2011) Charles F. Spurlock et al. ARTHRITIS AND RHEUMATISM
- Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis
- (2011) Laura Lovato et al. BRAIN
- Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing–remitting multiple sclerosis
- (2011) Roland Martin CLINICAL IMMUNOLOGY
- Immune mechanisms of new therapeutic strategies in MS — Teriflunomide
- (2011) Malte C. Claussen et al. CLINICAL IMMUNOLOGY
- Treatment of multiple sclerosis with Anti-CD20 antibodies
- (2011) Barbara Barun et al. CLINICAL IMMUNOLOGY
- B cells in multiple sclerosis: connecting the dots
- (2011) H-Christian von Büdingen et al. CURRENT OPINION IN IMMUNOLOGY
- An aggregation sensing reporter identifies leflunomide and teriflunomide as polyglutamine aggregate inhibitors
- (2011) Rodrigo A. Fuentealba et al. HUMAN MOLECULAR GENETICS
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- A role for interleukin-2 trans-presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy
- (2011) Simone C Wuest et al. NATURE MEDICINE
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis
- (2011) Aaron Boster et al. Therapeutic Advances in Neurological Disorders
- Pathophysiology of multiple sclerosis and the place of teriflunomide
- (2010) R. Gold et al. ACTA NEUROLOGICA SCANDINAVICA
- Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices
- (2010) Veronique E. Miron et al. AMERICAN JOURNAL OF PATHOLOGY
- Birth outcomes in women who have taken leflunomide during pregnancy
- (2010) Christina D. Chambers et al. ARTHRITIS AND RHEUMATISM
- Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
- (2010) Y. Iwata et al. BLOOD
- Therapy of MS
- (2010) Reza Vosoughi et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Metabolism in T cell activation and differentiation
- (2010) Erika L Pearce CURRENT OPINION IN IMMUNOLOGY
- An IL-2 Paradox: Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells
- (2010) J. F. Martin et al. JOURNAL OF IMMUNOLOGY
- Natalizumab treatment reduces endothelial activity in MS patients
- (2010) Alban Millonig et al. JOURNAL OF NEUROIMMUNOLOGY
- Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
- (2010) Christiane Wegner et al. JOURNAL OF NEUROIMMUNOLOGY
- A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
- (2010) Avijit Ray et al. JOURNAL OF NEUROIMMUNOLOGY
- Effects of Fumaric Acids on Cuprizone Induced Central Nervous System De- and Remyelination in the Mouse
- (2010) Darius Moharregh-Khiabani et al. PLoS One
- Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
- (2010) Ranjan Dutta et al. PROGRESS IN NEUROBIOLOGY
- Pathogenic CD8+T cells in multiple sclerosis
- (2009) Manuel A. Friese et al. ANNALS OF NEUROLOGY
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- Multiple sclerosis: Human model for EAE?
- (2009) Reinhard Hohlfeld EUROPEAN JOURNAL OF IMMUNOLOGY
- CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability
- (2009) Nico Melzer et al. FASEB JOURNAL
- Neuropathogenesis of Theiler’s Murine Encephalomyelitis Virus Infection, An Animal Model for Multiple Sclerosis
- (2009) Ikuo Tsunoda et al. Journal of Neuroimmune Pharmacology
- Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis
- (2009) Jean E. Merrill et al. JOURNAL OF NEUROLOGY
- C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
- (2009) Andrea Reboldi et al. NATURE IMMUNOLOGY
- Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate
- (2009) V. Skihar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- β1integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity
- (2009) Martina Bauer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemotherapy-Induced Alopecia
- (2009) Ralph M. Trüeb SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity
- (2009) M.L. Ritter et al. Transplant Infectious Disease
- Helminth infections associated with multiple sclerosis induce regulatory B cells
- (2008) Jorge Correale et al. ANNALS OF NEUROLOGY
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
- The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation
- (2008) Alla L. Zozulya et al. HUMAN IMMUNOLOGY
- The role of regulatory T cells in multiple sclerosis
- (2008) Alla L Zozulya et al. Nature clinical practice. Neurology
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
- (2007) John S. Tzartos et al. AMERICAN JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started